Projects per year
Organisation profile
Organisation profile
The TMU Research Center of Cancer Translational Medicine (RCCTM) is established through combining all cancer-related resources of TMU and its three affiliated hospitals. RCCTM is established with the goal of translating the research discoveries into state-of-the-art therapeutics for the prevention and treatment of cancer, as well as training future oncologists. We are committed to reduce the cancer burden through skilled, integrated and compassionate clinical care, and to eliminate the threat of cancer through research and education.
Fingerprint
Dive into the research topics where TMU Research Center of Cancer Translational Medicine is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Che-Chang Chang
- The Ph.D. Program for Translational Medicine - Professor
- Graduate Institute of Biomedical Informatics - Joint-Appointment Associate Professor
- International Ph.D. Program for Translational Science - Joint-Appointment Associate Professor
- Ph.D. Program in Drug Discovery and Development Industry - Joint-Appointment Associate Professor
- Master Program in Clinical Genomics and Proteomics - Joint-Appointment Associate Professor
- International Master Program for Translational Science - Joint Appointment Associate Prfoessor
- TMU Research Center of Drug Discovery - member
- TMU Research Center of Cell Therapy and Regeneration Medicine - member
- TMU Research Center of Cancer Translational Medicine - Member
Person: Researcher
-
Jang-Yang Chang
- TMU Research Center of Cancer Translational Medicine - University Chair Professor
- Taipei Medical University Hospital - Visiting Staff
Person: Researcher
-
Wei-Chiao Chang
- Department of Clinical Pharmacy - Professor
- Master Program in Applied Epidemiology - Joint-Appointment Professor
- Master Program in Clinical Genomics and Proteomics - Joint-Appointment Professor
- Ph.D. Program in Drug Discovery and Development Industry - Joint-Appointment Professor
- Ph. D. Program in the Clinical Drug Development of Herbal Medicine - Joint-Appointment Professor
- The Ph.D. Program for Translational Medicine - Joint-Appointment Professor
- Ph.D. Program in Medical Neuroscience - Joint-Appointment Professor
- TMU Research Center of Cancer Translational Medicine - Member
- TMU Research Center of Cell Therapy and Regeneration Medicine - member
Person: Researcher
-
115年高教深耕-癌症轉譯研究中心計畫
Chang, J.-Y. (PI)
1/1/26 → 12/31/26
Project: B - Project of TMU › h - Higher Education Sprout Project
-
Investigation of the Role of Cathepsin S in Regulation of Lysosome and Its Clinical Relevance in Head and Neck Cancer( II )
Chang, J.-Y. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Immune-Modulation of Nk Cells in Kidney Disease: Enhancing Therapeutic Performance by Crispr Gene Editing( I )
Chu, C.-Y. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
Research output
-
7,7”-dimethoxyagastisflavone induced MYCN/MYBL2-dependent apoptosis and metabolism reprogramming in Sonic Hedgehog medulloblastoma
Wu, Y. S., Lin, H. H., Wu, K. S., Huang, Y. T., Liao, J. Y., Chu, S. S., Wong, T. T., Hsieh, C. L., Chang, C. C., Sung, S. Y., Lin, C. Y. & Lin, Y. L., Dec 2026, In: Journal of Translational Medicine. 24, 1, 386.Research output: Contribution to journal › Article › peer-review
Open Access -
A calcium-sensing MCTP1/FYN/MEF2C circuit drives therapy-induced neuroendocrine prostate cancer
Dung, P. V. T., Chen, W. Y., Liu, M. K., Yeh, S. D., Kajla, G., Yeh, H. L., Chen, W. H., Jiang, K. C., Li, H. R., Chen, C. S., Beltran, H., Wen, Y. C. & Liu, Y. N., Jan 2026, In: Neoplasia (United States). 71, 101251.Research output: Contribution to journal › Article › peer-review
Open Access -
ADAM9 in tumor biology: molecular functions, clinical implications, and therapeutic targeting
Ho, K. H., Wu, C. J., Yang, Y. C. & Chien, M. H., Dec 2026, In: Cellular and Molecular Biology Letters. 31, 1, 74.Research output: Contribution to journal › Review article › peer-review
Open Access
Datasets
-
Additional file 4 of Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment
Ho, K.-H. (Contributor), Huang, T.-W. (Contributor), Shih, C.-M. (Contributor), Lee, Y.-T. (Creator), Liu, A.-J. (Contributor), Chen, P.-H. (Creator) & Chen, K.-C. (Creator), Figshare, 2021
DOI: 10.6084/m9.figshare.14111158.v1, https://springernature.figshare.com/articles/dataset/Additional_file_4_of_Glycolysis-associated_lncRNAs_identify_a_subgroup_of_cancer_patients_with_poor_prognoses_and_a_high-infiltration_immune_microenvironment/14111158/1
Dataset
-
Classic Ehlers–Dalnos syndrome presenting as atypical chronic haematoma: a case report with novel frameshift mutation in COL5A1
Chiu, W.-C. (Contributor), Chen, S.-H. (Contributor), Lo, M.-C. (Contributor) & Kuo, Y.-T. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5188708.v1, https://springernature.figshare.com/collections/Classic_Ehlers_Dalnos_syndrome_presenting_as_atypical_chronic_haematoma_a_case_report_with_novel_frameshift_mutation_in_COL5A1/5188708/1
Dataset
-
Additional file 2 of Classic Ehlers–Dalnos syndrome presenting as atypical chronic haematoma: a case report with novel frameshift mutation in COL5A1
Chiu, W.-C. (Contributor), Chen, S.-H. (Contributor), Lo, M.-C. (Contributor) & Kuo, Y.-T. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.13151758.v1, https://springernature.figshare.com/articles/figure/Additional_file_2_of_Classic_Ehlers_Dalnos_syndrome_presenting_as_atypical_chronic_haematoma_a_case_report_with_novel_frameshift_mutation_in_COL5A1/13151758/1
Dataset